Celltrion’s Biologics Stoboclo Receives Suppl Approval in US
10 Sep 2025 //
FDA
Celltrion’s Biologics Osenvelt Receives Suppl Approval in US
10 Sep 2025 //
FDA
Horizon`s Biologics Tepezza Receives Suppl Approval in US
09 Sep 2025 //
FDA
Aurobindo’s Generics Deferasirox Receives Approval in US
08 Sep 2025 //
FDA
Epic’s Generics Ivermectin Receives Approval in US
08 Sep 2025 //
FDA
Aurobindo’s Generics Prochlorperazine Receives Approval in US
08 Sep 2025 //
FDA
Alembic`s Generics Phytonadione Receives Approval in US
08 Sep 2025 //
FDA
MSN’s Generics Dapagliflozin Receive Tentative Approval in US
05 Sep 2025 //
FDA
Genentech`s Biologics Susvimo Receives Supple Approval in US
05 Sep 2025 //
FDA
Torrent`s Generics Pazopanib HCl Receives Approval in US
04 Sep 2025 //
FDA
Eskayef`s Generics Paliperidone Receives Approval in US
04 Sep 2025 //
FDA
Ajanta`s Generics Topiramate Receives Approval in US
03 Sep 2025 //
FDA
Hopewell`s Generics Sapropterin 2HCl Receives Approval in US
03 Sep 2025 //
FDA
Steriscience`s Generics Ziprasidone Receives Approval in US
03 Sep 2025 //
FDA
Janssen`s Biologics Rybrevant Receives Suppl Approval in US
03 Sep 2025 //
FDA
Abbvie Inc`s Biologics Skyrizi Receives Suppl Approval in US
03 Sep 2025 //
FDA
Nanomi`s Generics Risperidone Receives Approval in US
02 Sep 2025 //
FDA
Amneal`s Generics Risperidone Receives Approval in US
02 Sep 2025 //
FDA
AbbVie’s Elahere Approved in Canada
29 Aug 2025 //
HEALTH CANADA
Henlius’s Biologics Bilprevda Receives Approval in US
29 Aug 2025 //
FDA
Henlius’s Biologics Bildyos Receives Approval in US
29 Aug 2025 //
FDA
Eisai’s Biologics Leqembi Receives Approval in US
29 Aug 2025 //
FDA
Kyowa Kirin’s Biologics Crysvita Receives Suppl Approval in US
28 Aug 2025 //
FDA
Y-mAbs’s Biologics Danyelza Receives Suppl Approval in US
27 Aug 2025 //
FDA
Teva’s Generics Liraglutide Receives Approval in US
27 Aug 2025 //
FDA
USV’s Generics Sugammadex Receives Tentative Approval in US
27 Aug 2025 //
FDA
Horizon’s Biologics Tepezza Receives Suppl Approval in US
26 Aug 2025 //
FDA
Leo Pharma`s Anzupgo Approved in Canada
25 Aug 2025 //
HEALTH CANADA
Alembic’s Generics Melphalan Gets Tentative Approval in US
25 Aug 2025 //
FDA
Lupin’s Generics Dasatinib Receives FDA Approval in US
25 Aug 2025 //
FDA
Amgen’s Biologics Avsola Recieves Suppl Approval in US
25 Aug 2025 //
FDA
Samsung Bioepis’s Biologics Opuviz Recives Suppl Approval in US
25 Aug 2025 //
FDA
Sandoz’s Biologics Zarxio Receives Suppl Approval in US
21 Aug 2025 //
FDA
Amgen’s Biologics Repatha Receives Suppl Approval in US
21 Aug 2025 //
FDA
Somerset’s Generics Rilpivirine Receives Tentative Approval in US
20 Aug 2025 //
FDA
King Friend`s Generics Nicardipine HCl Receives Approval in US
20 Aug 2025 //
FDA
Janssen’s Biologics Talvey Receives Suppl Approval in US
19 Aug 2025 //
FDA
Janssen’s Biologics Tecvayli Receives Suppl Approval in US
19 Aug 2025 //
FDA
Genentech’s Biologic Ocrevus Zunovo Receives Suppl Approval in US
18 Aug 2025 //
FDA
Genentech’s Biologics Tecentriq Receives Suppl Approval in US
18 Aug 2025 //
FDA
TG Therapeutics`s Biologics Briumvi Receives Suppl Approval in US
18 Aug 2025 //
FDA
Iovance Bio’s Amtagvi Approved in Canada
15 Aug 2025 //
HEALTH CANADA
Elc Group`s Usymro Receives Approval in Europe
14 Aug 2025 //
EMA
Upsher Labs`s Generics Deflazacort Receives Approval in US
11 Aug 2025 //
FDA
Gland`s Generics Cangrelor Receives Approval in US
11 Aug 2025 //
FDA
Aurobindo Pharma`s Generics Pirfenidone Receives Approval in US
11 Aug 2025 //
FDA
Gilead Sciences`s Hepcludex Receives Approval in Canada
08 Aug 2025 //
FDA
Zydus`s Generics Diltiazem Hydrochloride Receives Approval in US
08 Aug 2025 //
FDA
CSL Behring`s Andembry Receives Approval in Canada
06 Aug 2025 //
HEALTH CANADA
Teva`s Biologics Ajovy Receives Suppl Approval in US
05 Aug 2025 //
FDA
Jubilant`s Generics Eslicarbazepine Receives Approval in US
04 Aug 2025 //
FDA
FDC`s Generics Moxifloxacin HCl Receives Approval in US
04 Aug 2025 //
FDA
Sanofi`s Avapro Receives Approval in US
01 Aug 2025 //
FDA
Sandoz`s Biologics Hyrimoz Receives Suppl Approval in US
29 Jul 2025 //
FDA
Ascendis`s Biologics Skytrofa Receives Suppl Approval in US
25 Jul 2025 //
FDA
Alembic`s Generics Carbamazepine Receives Approval in US
25 Jul 2025 //
FDA
Annora`s Generics Spironolactone Receives Approval in US
25 Jul 2025 //
FDA
Hetero`s Generics HCTZ Olmesartan Receives Approval in US
25 Jul 2025 //
FDA
MPP Pharma`s Generics Niacin Receives Approval in US
25 Jul 2025 //
FDA
MSN`s Generics Famotidine Receives Approval in US
24 Jul 2025 //
FDA